165 related articles for article (PubMed ID: 26956973)
1. Tristetraprolin mediates the anti-proliferative effects of metformin in breast cancer cells.
Pandiri I; Chen Y; Joe Y; Kim HJ; Park J; Chung HT; Park JW
Breast Cancer Res Treat; 2016 Feb; 156(1):57-64. PubMed ID: 26956973
[TBL] [Abstract][Full Text] [Related]
2. Tristetraprolin induces cell cycle arrest in breast tumor cells through targeting AP-1/c-Jun and NF-κB pathway.
Xu L; Ning H; Gu L; Wang Q; Lu W; Peng H; Cui W; Ying B; Ross CR; Wilson GM; Wei L; Wold WS; Liu J
Oncotarget; 2015 Dec; 6(39):41679-91. PubMed ID: 26497679
[TBL] [Abstract][Full Text] [Related]
3. Functional switching of TGF-beta1 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter.
Sohn BH; Park IY; Lee JJ; Yang SJ; Jang YJ; Park KC; Kim DJ; Lee DC; Sohn HA; Kim TW; Yoo HS; Choi JY; Bae YS; Yeom YI
Gastroenterology; 2010 May; 138(5):1898-908. PubMed ID: 20038433
[TBL] [Abstract][Full Text] [Related]
4. Mammary differentiation induces expression of Tristetraprolin, a tumor suppressor AU-rich mRNA-binding protein.
Goddio MV; Gattelli A; Slomiansky V; Lacunza E; Gingerich T; Tocci JM; Facchinetti MM; Curino AC; LaMarre J; Abba MC; Kordon EC
Breast Cancer Res Treat; 2012 Oct; 135(3):749-58. PubMed ID: 22968621
[TBL] [Abstract][Full Text] [Related]
5. A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients.
Griseri P; Bourcier C; Hieblot C; Essafi-Benkhadir K; Chamorey E; Touriol C; Pagès G
Hum Mol Genet; 2011 Dec; 20(23):4556-68. PubMed ID: 21875902
[TBL] [Abstract][Full Text] [Related]
6. PIM2 interacts with tristetraprolin and promotes breast cancer tumorigenesis.
Ren C; Yang T; Qiao P; Wang L; Han X; Lv S; Sun Y; Liu Z; Du Y; Yu Z
Mol Oncol; 2018 May; 12(5):690-704. PubMed ID: 29570932
[TBL] [Abstract][Full Text] [Related]
7. Tumor suppressor p53 plays a key role in induction of both tristetraprolin and let-7 in human cancer cells.
Lee JY; Kim HJ; Yoon NA; Lee WH; Min YJ; Ko BK; Lee BJ; Lee A; Cha HJ; Cho WJ; Park JW
Nucleic Acids Res; 2013 Jun; 41(11):5614-25. PubMed ID: 23595149
[TBL] [Abstract][Full Text] [Related]
8. Tristetraprolin suppresses AHRR expression through mRNA destabilization.
Lee HH; Kim WT; Kim DH; Park JW; Kang TH; Chung JW; Leem SH
FEBS Lett; 2013 May; 587(10):1518-23. PubMed ID: 23583445
[TBL] [Abstract][Full Text] [Related]
9. Tristetraprolin activation by resveratrol inhibits the proliferation and metastasis of colorectal cancer cells.
Lee SR; Jin H; Kim WT; Kim WJ; Kim SZ; Leem SH; Kim SM
Int J Oncol; 2018 Sep; 53(3):1269-1278. PubMed ID: 29956753
[TBL] [Abstract][Full Text] [Related]
10. Depletion of tristetraprolin in breast cancer cells increases interleukin-16 expression and promotes tumor infiltration with monocytes/macrophages.
Milke L; Schulz K; Weigert A; Sha W; Schmid T; Brüne B
Carcinogenesis; 2013 Apr; 34(4):850-7. PubMed ID: 23241166
[TBL] [Abstract][Full Text] [Related]
11. The over-expression of miR-34a fails to block DoHH2 lymphoma cell proliferation by reducing p53 via c-MYC down-regulation.
Rizzo M; Mariani L; Cavallini S; Simili M; Rainaldi G
Nucleic Acid Ther; 2012 Aug; 22(4):283-8. PubMed ID: 22830357
[TBL] [Abstract][Full Text] [Related]
12. CREB targets define the gene expression signature of malignancies having reduced levels of the tumor suppressor tristetraprolin.
Fallahi M; Amelio AL; Cleveland JL; Rounbehler RJ
PLoS One; 2014; 9(12):e115517. PubMed ID: 25541715
[TBL] [Abstract][Full Text] [Related]
13. Gene transduction of tristetraprolin or its active domain reduces TNF-alpha production by Jurkat T cells.
Suzuki E; Tsutsumi A; Goto D; Matsumoto I; Ito S; Otsu M; Onodera M; Takahashi S; Sato Y; Sumida T
Int J Mol Med; 2006 May; 17(5):801-9. PubMed ID: 16596264
[TBL] [Abstract][Full Text] [Related]
14. [Coordination inhibition of the proliferation of MCF-7 by enhancing expression of p53,p21 and decreasing expression of c-myc].
Zhang HJ; Wang N; Zhu XY; Sang JL; He DC
Shi Yan Sheng Wu Xue Bao; 2005 Feb; 38(1):16-22. PubMed ID: 15839202
[TBL] [Abstract][Full Text] [Related]
15. The RNA-binding zinc-finger protein tristetraprolin regulates AU-rich mRNAs involved in breast cancer-related processes.
Al-Souhibani N; Al-Ahmadi W; Hesketh JE; Blackshear PJ; Khabar KS
Oncogene; 2010 Jul; 29(29):4205-15. PubMed ID: 20498646
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of protein kinase Cdelta reduces tristetraprolin expression by destabilizing its mRNA in activated macrophages.
Leppänen T; Jalonen U; Korhonen R; Tuominen RK; Moilanen E
Eur J Pharmacol; 2010 Feb; 628(1-3):220-5. PubMed ID: 19925787
[TBL] [Abstract][Full Text] [Related]
17. TTP mediates cisplatin-induced apoptosis of head and neck cancer cells by down-regulating the expression of Bcl-2.
Park SB; Lee JH; Jeong WW; Kim YH; Cha HJ; Joe Y; Chung HT; Cho WJ; Do JW; Lee BJ; Park JW; Ko BK
J Chemother; 2015 Jun; 27(3):174-80. PubMed ID: 25604244
[TBL] [Abstract][Full Text] [Related]
18. Tristetraprolin exerts tumor suppressive functions on the tumorigenesis of glioma by targeting IL-13.
Zeng B; Zhu D; Su Z; Li Z; Yu Z
Int Immunopharmacol; 2016 Oct; 39():63-70. PubMed ID: 27424080
[TBL] [Abstract][Full Text] [Related]
19. Tristetraprolin: a novel mediator of the anticancer properties of resveratrol.
Li C; Tang C; He G
Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27323060
[TBL] [Abstract][Full Text] [Related]
20. The role of c-Myc-RBM38 loop in the growth suppression in breast cancer.
Li XX; Shi L; Zhou XJ; Wu J; Xia TS; Zhou WB; Sun X; Zhu L; Wei JF; Ding Q
J Exp Clin Cancer Res; 2017 Apr; 36(1):49. PubMed ID: 28399911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
